文献速递烧伤创面修复

MR-proADM:烧伤患者脓毒症早期诊断的新生物标志物

MR-proADM: A New Biomarker for Early Diagnosis of Sepsis in Burned Patients.
PubMed 文献 · J Burn Care Res · 2017-01-01

前瞻性观察研究纳入42例烧伤面积>15% TBSA患者,伤后20天内每日检测MR-proADM与降钙素原(PCT)。27例(64.3%)发生脓毒症,其脓毒症日两种标志物均显著高于非脓毒症日(P < .001);PCT在脓毒症首日升高,MR-proADM提前一天升高,提示MR-proADM更适于早期识别脓毒症。

要点

  • 烧伤后MR-proADM与PCT先升后降,无脓毒症者第2天达峰。
  • 脓毒症日MR-proADM与PCT均显著高于非脓毒症日(P < .001)。
  • MR-proADM较PCT提前一天升高,更适于脓毒症早期识别。

核心结论

  • 烧伤本身可致MR-proADM升高,后续再升高可视为脓毒症发病的诊断依据。
  • PCT特异性与敏感性更高,而MR-proADM可能更适合脓毒症的早期识别。

研究设计与样本

  • 前瞻性观察研究,连续纳入42例烧伤面积>15% TBSA患者。
  • 伤后初始20天每日采血,用免疫发光夹心法检测MR-proADM与PCT。

主要发现

  • 无脓毒症患者MR-proADM与PCT在伤后升高,入院第2天达峰后持续下降。
  • 27例(64.3%)发生脓毒症,脓毒症日MR-proADM与PCT显著高于非脓毒症日(P < .001)。
  • PCT在脓毒症首日升高,MR-proADM提前一天升高。

关键数值与推荐

  • MR-proADM诊断脓毒症的最佳界值:升高31%且至少0.015 nmol/L(AUC 0.76)。
  • PCT诊断脓毒症的最佳界值:升高>39%且至少0.15 µg/L(AUC 0.83)。

临床怎么用

  • 烧伤患者可动态监测MR-proADM,其较PCT提前一天升高,有助于早期预警脓毒症。
  • 结合PCT较高特异性与敏感性,两者联合或可优化脓毒症诊断流程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mid regional pro-adrenomedullin (MR-proADM) has been used as a marker of sepsis, but its dynamics and role in a burn injury setting has not been tested. In a prospective observational study, we included 42 consecutive patients with >15% TBSA. Daily blood specimens collected over the initial 20 days of treatment were submitted for laboratory analysis of MR-proADM and procalcitonin (PCT) via immunoluminometric sandwich assay (Kryptor, BRAHMS, Berlin, Germany). In patients with an absence of sepsis, an initial increase in MR-proADM and PCT levels was noted post-burn injury, peaking on the second day postadmission and thereafter demonstrated a continued decline in MR-proADM and PCT levels. In those patients who went on to develop sepsis (n = 27, 64.3%), the levels of MR-proADM and PCT were significantly higher (P < .001) on days categorized as septic, than on days categorized as nonseptic. The increase in PCT levels was noted on the first day to be categorized as septic. In contrast, the MR-proADM levels demonstrated an increase one day earlier. The optimal relationship between the specificity and sensitivity of MR-proADM and PCT for the detection of sepsis was an increase of 31% and at least 0.015 nmol/L (area under curve 0.76) or of >39% and at least 0.15 µg/L (area under the curve 0.83), respectively. Burn injury is associated with increased levels of MR-proADM. Subsequent increases may be considered as diagnostic of sepsis onset. In this context, PCT displayed higher specificity and sensitivity, while MR-proADM may be more suitable for the early recognition of sepsis (ClinicalTrials.gov number, NCT01055587).

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Gille J, Ostermann H, Dragu A, et al. MR-proADM: A New Biomarker for Early Diagnosis of Sepsis in Burned Patients. J Burn Care Res. 2017. PMID: 28221298. doi:10.1097/BCR.0000000000000508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。